W. Cieślikowski

Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors

H. Bluyssen, R. Giles, J. Wesoły, 2015, BMC Cancer.

Co-administration of tyrosine kinase inhibitors with rottlerin in metastatic prostate cancer cells

A. Hasenburg, W. Brenner, J. Thüroff, 2021, EXCLI Journal.

Clinical Relevance of Circulating Tumor Cells in Prostate Cancer Management

M. Nowicki, M. Zabel, A. Antczak, 2021, Biomedicines.

Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer

K. Pantel, M. Nowicki, M. Zabel, 2020, Cancers.

Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays

K. Pantel, M. Nowicki, M. Zabel, 2019, Cancers.

Reasons behind the Delayed Diagnosis of Testicular Cancer: A Retrospective Analysis

A. Antczak, Michał Kasperczak, T. Milecki, 2023, International journal of environmental research and public health.

Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate Cancer

K. Pantel, M. Nowicki, M. Zabel, 2023, Journal of personalized medicine.

Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays

K. Pantel, M. Nowicki, M. Zabel, 2019, Cancers.